中国临床医学
中國臨床醫學
중국림상의학
CLINICAL MEDICAL JOURNAL OF CHINA
2014年
3期
273-275
,共3页
陶金好%陈伟明%胡静%贺骏%马健%陆铸今%陆国平
陶金好%陳偉明%鬍靜%賀駿%馬健%陸鑄今%陸國平
도금호%진위명%호정%하준%마건%륙주금%륙국평
急性肝衰竭%非生物型人工肝%儿童
急性肝衰竭%非生物型人工肝%兒童
급성간쇠갈%비생물형인공간%인동
Acute liver failure%Non-bioartificial liver%Children
目的:探讨非生物型人工肝治疗儿童急性肝衰竭(acute liver failure ,ALF)的疗效。方法:回顾分析2008年8月-2013年7月复旦大学附属儿科医院收治的47例儿童ALF患者的临床资料,其中17例患者采用常规内科综合治疗(对照组),30例患者在常规内科综合治疗基础上采用非生物型人工肝治疗(研究组),分析ALF患儿的年龄分布特征及病因情况,比较研究组患儿治疗前后主要生化指标、凝血功能指标的变化以及2组患儿病死率。结果:47例 ALF患儿中≤1岁患儿23例、1~3岁10例、≥3岁14例;34.0%患儿病因不明。与治疗前比较,研究组患儿治疗后血清总胆红素(total bilirubin ,TBIL )、丙氨酸氨基转移酶(alanine aminotransferase ,ALT)、天门冬氨酸氨基转移酶(aspartate aminotransferase ,AST)均降低(P<0.05),国际化标准比值(international normalized ratio ,INR)、凝血酶原活度(prothrombin time activity ,PTA)、白蛋白(albumin ,ALB)均升高(P<0.05)。研究组病死率低于对照组,但差异无统计学意义。结论:非生物型人工肝治疗儿童ALF是有效的,可改善患儿的生化指标、凝血功能及预后。
目的:探討非生物型人工肝治療兒童急性肝衰竭(acute liver failure ,ALF)的療效。方法:迴顧分析2008年8月-2013年7月複旦大學附屬兒科醫院收治的47例兒童ALF患者的臨床資料,其中17例患者採用常規內科綜閤治療(對照組),30例患者在常規內科綜閤治療基礎上採用非生物型人工肝治療(研究組),分析ALF患兒的年齡分佈特徵及病因情況,比較研究組患兒治療前後主要生化指標、凝血功能指標的變化以及2組患兒病死率。結果:47例 ALF患兒中≤1歲患兒23例、1~3歲10例、≥3歲14例;34.0%患兒病因不明。與治療前比較,研究組患兒治療後血清總膽紅素(total bilirubin ,TBIL )、丙氨痠氨基轉移酶(alanine aminotransferase ,ALT)、天門鼕氨痠氨基轉移酶(aspartate aminotransferase ,AST)均降低(P<0.05),國際化標準比值(international normalized ratio ,INR)、凝血酶原活度(prothrombin time activity ,PTA)、白蛋白(albumin ,ALB)均升高(P<0.05)。研究組病死率低于對照組,但差異無統計學意義。結論:非生物型人工肝治療兒童ALF是有效的,可改善患兒的生化指標、凝血功能及預後。
목적:탐토비생물형인공간치료인동급성간쇠갈(acute liver failure ,ALF)적료효。방법:회고분석2008년8월-2013년7월복단대학부속인과의원수치적47례인동ALF환자적림상자료,기중17례환자채용상규내과종합치료(대조조),30례환자재상규내과종합치료기출상채용비생물형인공간치료(연구조),분석ALF환인적년령분포특정급병인정황,비교연구조환인치료전후주요생화지표、응혈공능지표적변화이급2조환인병사솔。결과:47례 ALF환인중≤1세환인23례、1~3세10례、≥3세14례;34.0%환인병인불명。여치료전비교,연구조환인치료후혈청총담홍소(total bilirubin ,TBIL )、병안산안기전이매(alanine aminotransferase ,ALT)、천문동안산안기전이매(aspartate aminotransferase ,AST)균강저(P<0.05),국제화표준비치(international normalized ratio ,INR)、응혈매원활도(prothrombin time activity ,PTA)、백단백(albumin ,ALB)균승고(P<0.05)。연구조병사솔저우대조조,단차이무통계학의의。결론:비생물형인공간치료인동ALF시유효적,가개선환인적생화지표、응혈공능급예후。
Objective:To investigate the clinical effectiveness of non-bioartificial liver in the treatment of children with acute liver failure(ALF) .Methods :The clinical datum of 47 children with ALF from Aug 2008 to Jul 2013 treated in Children's Hos-pital ,Fudan University were retrospectively analyzed .Among them ,17 children were treated with only conventional compre-hensive medical treatment (control group) ,and the other 30 children were treated with non-bioartificial liver in addition to con-ventional comprehensive medical treatment (study group) .The distributing characteristics of age and etiological factors were analyzed .The main biochemical parameters and coagulation function parameters before and after treatment were compared in the study group and mortality rate was compared between the two groups .Results:In 47 children with ALF ,the cases ≤1 year old ,1-3 years old and ≥3 years old were 23 ,10 and 14 ,respectively .The percentage of unknown reasons in children with ALF was 34 .0% .Compared with before treatment ,serum total bilirubin(TBIL) ,alanine aminotransferase(ALT) and aspartate ami-notransferase(AST) decreased after treatment in the study group (P< 0 .05) ,and international normalized ratio (INR) ,pro-thrombin time activity(PTA) ,and albumin(ALB) significantly increased(P<0 .05) .The mortality rate in the study group was lower than that in the control group ,but the difference was not statistically significant .Conclusions :Non-bioartificial liver is effective for the treatment of children with ALF ,and can improve biochemical parameters ,coagulation function and prognosis .